SLM Solutions Group AG

  • WKN: A11133
  • ISIN: DE000A111338
  • Land: Deutschland

Nachricht vom 12.07.2021 | 22:43

SLM Solutions Group AG Upsizes Capital Increase from Authorized Capital Following Strong Demand

SLM Solutions Group AG / Key word(s): Capital Increase
SLM Solutions Group AG Upsizes Capital Increase from Authorized Capital Following Strong Demand

12-Jul-2021 / 22:43 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Disclosure of inside information pursuant to Article 17 of the Regulation (EU) No 596/2014

NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA AND JAPAN OR ANY JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.

SLM Solutions Group AG Upsizes Capital Increase from Authorized Capital Following Strong Demand

Luebeck, 12 July 2021 - SLM Solutions Group AG (ISIN DE000A111338, the "Company") announces that, following strong demand, the Company has decided to upsize their previously announced capital increase from authorized capital from up to 5% to up to, in total, 7.3% of the outstanding share capital. The share capital of the Company will be increased from currently EUR 19,778,953.00 to now up to EUR 21,228,953.00 through issuing up to 1,450,000 new shares, making partial use of the Authorized Capital 2021.

The new shares will be offered to qualified institutional investors by way of a private placement. The shareholders' statutory subscription right is excluded in accordance with Section 203 AktG in conjunction with Section 186 (3) sentence 4 AktG. The new shares are expected to be included in the existing listing of the shares of the Company at the Frankfurt Stock Exchange on or around 16 July 2021.

Additional proceeds coming from the upsized transaction will be used for growth financing.

Books have opened earlier today and may close at short notice. In the context of the contemplated capital increase, the Company has agreed to a lock-up period of 180 days subject to customary market exceptions and, as already announced, the possible issuance of further securities in accordance with the terms and conditions of the convertible bonds issued by the Company in 2020 and 2021.

Important Notice

This publication may not be published or distributed or transmitted, directly or indirectly, in the United States of America (including its territories and possessions), Australia, Canada, Japan or any other jurisdiction where such an announcement would be unlawful. The distribution of this announcement may be restricted by law in certain jurisdictions and persons who are in possession of this document or other information referred to herein should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This publication does not constitute an offer or a solicitation to submit an offer to purchase, any securities of the Company or any its subsidiaries in the United States of America, Germany or any other jurisdiction. Neither this announcement nor its content shall form the basis of an offer in any jurisdiction or may be deemed as binding in connection with such an offer. The offered shares have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold in the United States of America without registration or an exemption from registration under the Securities Act.

In the United Kingdom, this publication is being directed only at persons who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") or (ii) persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, partnerships, etc.) (all such persons together being referred to as "Relevant Persons"). This publication is directed and distributed only to Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this publication relates is available only to Relevant Persons and will be engaged in only with Relevant Persons.

In the member states of the European Economic Area, the placement of securities described in this announcement is directed exclusively to persons who are qualified investors in the meaning of the Regulation (EU) 2017/1129 of the European Parliament and the Council of 14 June 2017 (Prospectus Regulation).

No action has been taken that would permit an offer or a purchase of the securities or distribution of this publication in any jurisdiction where such action would be unlawful. Persons who are in possession of this announcement are required to inform themselves about and observe any such restrictions.

This announcement does not constitute a recommendation concerning the placement. Investors should consult a professional advisor as to the suitability of the placement for the person concerned.

---- End of ad hoc announcement ----


12-Jul-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie

3U HOLDING AG

Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021